Bio Medica Laboratories IPO
ForthcomingBio Medica Laboratories IPO Details
-
Bidding Date
21-May-2026 to
25-May-2026 -
Issue Size
₹52.43 Cr
-
Price Band
₹132 to ₹139
-
Allotment date
26-May-2026
-
Listing date
To be updated
-
Lot size
1000
-
No. of shares
37,72,000
-
Fresh issue/OFS
₹47.19 Cr/₹5.24 Cr
About Bio Medica Laboratories Company
Bio Medica Laboratories was founded in 1988 by Pradeep Johari and has developed from a pharmaceutical manufacturing background into a broader lab-testing and quality-assurance business focused on regulated healthcare support. Its core activities now center on pharmaceutical testing, microbiological analysis, water testing, method validation, and stability studies, serving pharmaceutical companies, healthcare providers, and manufacturers that need compliant product and process verification. The company’s expertise includes work across IP, BP, USP, and WHO standards, with strengths in precision testing, documentation, and the use of modern instrumentation to deliver reliable results. Its approach is built around scientific rigor, regulatory compliance, and client support, helping customers manage quality, safety, and consistency across pharmaceutical and related products.
Subscription Status
-
Category
Status
-
QIBs
--
-
NIIs
--
-
Retail
--
-
Others
--
-
Total
--
FAQs for Bio Medica Laboratories IPO.
What is the issue size of Bio Medica Laboratories IPO?
The issue size of Bio Medica Laboratories is ₹52.43 Cr.
What is the industry of Bio Medica Laboratories?
Bio Medica Laboratories falls into Pharmaceuticals industry.
What are the open and close dates for the Bio Medica Laboratories IPO?
The open and close dates for the Bio Medica Laboratories are 21-May-2026 & 25-May-2026.
What are the price band for Bio Medica Laboratories IPO?
The price band for the Bio Medica Laboratories ipo is ₹132 to ₹139
What is the purpose for the Bio Medica Laboratories IPO?
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
What are the key financials for the Bio Medica Laboratories IPO?
Key financial of the Bio Medica Laboratories are:
| Bio Medica Laboratories | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 38.2 | 15.25 | 16.23 |
| EBIT (₹ Cr) | 14.37 | 4.52 | 1.2 |
| Proft after Tax (₹ Cr) | 9.79 | 2.5 | 0.33 |
| Debt (₹ Cr) | 15.01 | 10.49 | 9.61 |
| Net Worth (₹ Cr) | 14.73 | 4.94 | 2.44 |
| RoE (%) | 66.48 | 50.6 | 13.67 |